|
Volumn 55, Issue 2, 2000, Pages 285-293
|
Current trends in the management of chronic obstructive pulmonary disease
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BECLOMETASONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA LACTAM ANTIBIOTIC;
BUDESONIDE;
CEPHALOSPORIN DERIVATIVE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
FLUTICASONE;
IPRATROPIUM BROMIDE;
IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;
OXYGEN;
PREDNISONE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
THEOPHYLLINE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
HAEMOPHILUS INFLUENZAE;
HUMAN;
INFECTION PREVENTION;
LUNG FUNCTION TEST;
LUNG RESECTION;
MALAYSIA;
OXYGEN THERAPY;
PRACTICE GUIDELINE;
PREVALENCE;
REVIEW;
SMOKING CESSATION;
SURVIVAL RATE;
ADRENAL CORTEX HORMONES;
ANTI-BACTERIAL AGENTS;
BRONCHODILATOR AGENTS;
EDUCATION, MEDICAL, CONTINUING;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
MALE;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SMOKING CESSATION;
|
EID: 0033774805
PISSN: 03005283
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (32)
|